Dr Wise,

I have a question on the umbilical cord blood mononuclear cells (UCBMC) and lithium in clinical trial. Please correct me if I am wrong but I believe I have read that in the trail UCBMC will be injected before and after the injury site.

My question is how close to the injury site do the injections need to take place? The reason I am asking is because in my case, and probably many others, the injury site will not be easy reached due to “hardware” and/or bone fusion. As an example I have rods the length of my spine and my ribs are graphed as sort of make shift vertebrae for stabilization. I had a bone scan and it appears that there are a few inches of dense bone surrounding the injury, making the site difficult to reach. From your knowledge of UCBMC do you suppose the cell can be injected approximately an inch or two away from the site, will they travel?

Thank you in advance.